Pazopanib
- Product NDC
- 60505-4779
- 11-digit product format
- 605054779
- Labeler code
- 60505
- Product ID
- 60505-4779_13431d63-13a5-2a76-c6de-06799bc59e29
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pazopanib
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA217713
- Marketing category
- ANDA
- Marketing start
- 2023-10-19
- Substance
- PAZOPANIB
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pazopanib
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PAZOPANIB | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7RN5DR86CK |
| Rxcui | 867502 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60505-4779-5 | Pazopanib | 500 in 1 BOTTLE | TABLET | 500 | | 4 |
| 60505-4779-7 | Pazopanib | 120 in 1 BOTTLE | TABLET | 120 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-4779 | PAZOPANIB TABLET [APOTEX CORP.] | 3 | Current NDC, 2 package rows | 20240301_b05ea49a-a764-5ff2-6e4a-26add69da9e2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 60505-4779-5 | 60505477905 | 500 TABLET in 1 BOTTLE (60505-4779-5) | 500 tablet | 2023-10-19 | No | No | Historical |
| 60505-4779-7 | 60505477907 | 120 TABLET in 1 BOTTLE (60505-4779-7) | 120 tablet | 2023-10-19 | No | No | Historical |